54 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data https://www.zacks.com/stock/news/2246931/viking-vktx-up-17-on-encouraging-oral-obesity-drug-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246931 Mar 27, 2024 - Data from an early-stage study shows that patients who received Viking's (VKTX) orally-administered obesity drug lost up to 5.3% of their body weight after 28 days.
Eli Lilly (LLY) Advances While Market Declines: Some Information for Investors https://www.zacks.com/stock/news/2246297/eli-lilly-lly-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2246297 Mar 26, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $774.90, indicating a +0.23% shift from the previous trading day.
Wall Street Awaits Consumer Confidence Data https://www.zacks.com/stock/news/2246106/wall-street-awaits-consumer-confidence-data?cid=CS-ZC-FT-economic_highlights-2246106 Mar 26, 2024 - Wall Street Awaits Consumer Confidence Data
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings https://www.zacks.com/stock/news/2245863/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245863 Mar 26, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk? https://www.fool.com/investing/2024/03/22/with-shares-near-all-time-highs-is-it-a-buy/?source=iedfolrf0000001 Mar 22, 2024 - The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation https://www.fool.com/investing/2024/03/17/3-unstoppable-stocks-you-can-buy-now-without-any/?source=iedfolrf0000001 Mar 17, 2024 - There's no need for delays in buying these great stocks.
Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH https://www.zacks.com/stock/news/2241318/madrigal-mdgl-stock-up-as-fda-approves-first-drug-for-nash?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2241318 Mar 15, 2024 - Madrigal Pharmaceuticals' (MDGL) Rezdiffra (resmetirom) is the first and only medicine approved by the FDA for the treatment of NASH.
Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More https://www.zacks.com/stock/news/2241296/pharma-stock-roundup-azn-s-new-acquisition-fda-updates-for-nvo-lly-and-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2241296 Mar 15, 2024 - AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lilly's (LLY) donanemab and approves Novo Nordisk's (NVO) Wegovy for reducing cardiovascular risks.
The Best Stocks to Invest $50,000 in Right Now https://www.fool.com/investing/2024/03/09/the-best-stocks-to-invest-50000-in-right-now/?source=iedfolrf0000001 Mar 09, 2024 - These stalwart companies can help you grow your wealth.
S&P 500 Soars to New Highs: 5 Best Stocks YTD https://www.zacks.com/stock/news/2238098/s-p-500-soars-to-new-highs-5-best-stocks-ytd?cid=CS-ZC-FT-etf_news_and_commentary-2238098 Mar 08, 2024 - The S&P 500 soared to new all-time highs on reassuring comments regarding potential interest rate declines. SPDR S&P 500 ETF Trust (SPY), the proxy version of the S&P 500 Index, has risen 8.3% so far this year.

Pages: 123456

Page 1>